The increase in FGF21 expression in CPSS cats in our study could reflect an adaption, to prevent hepatotoxicity from endoplasmic reticulum (ER) stress [39], but further investigations of FGF21 function in cats is required to determine its potential as either a biomarker for liver disease or as a possible therapeutic agent. This evidence concerns the gene FGF21 and liver disorder.